References
- Folley, R N.; Parfey, P S.; Sarnak, M J.Clinical epidemiology of cardiovascular disease in chronic renal failure. Am. J. Kidney Dis. 1998, 32, 112–119.
- Stenvinkel, P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001, 19, 53–61. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Danesh, J.; Collins, R.; Peto, R. Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350, 430–436. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stevenson, F. Inflammation and end-stage renal disease: recent insights. Semin. Dial. 1998, 11, 119–123.
- Ross, R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999, 340, 115–126. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stenvinkel, P.; Heimburger, O.; Lindholm, B.; Kaysen, G A.; Bergstrom, J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant. 2000, 15, 953–960. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bergstrom, J.; Levey, A S. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients. J. Am. Soc. Nephrol. 1995, 6, 573.
- Zimmerman, J.; Herrlinger, S.; Pruy, A.; Metzger, T.; Wanner, C. Inflammation enchances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999, 55, 648–658. [CROSSREF]
- Assicot, M.; Gendrel, D.; Carsin, H.; Raymond, J.; Guilbaud, J.; Bohuon, C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341, 515–518. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bernard, L.; Ferriere, F.; Casassus, P.; Malas, F.; Leveque, S.; Guillevin, L.; Lortholary, O. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin. Infect. Dis. 1998, 27, 914–915. [PUBMED], [INFOTRIEVE], [CSA]
- Schwenger, V.; Sis, J.; Breitbart, A.; Andrassy, K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998, 26, 274–276. [PUBMED], [INFOTRIEVE]
- Experts from United States Renal Data System 1999. Annual data report. Am. J. Kidney Dis. 1999, 34, 1–176.
- Bossink, A.; Groeneveld, J.; Lambertus, G. Predictor of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-α–antitrypsin and lactoferrin compared with clinical variables. Clin. Infect. Dis. 1999, 29, 398–407. [PUBMED], [INFOTRIEVE], [CSA]
- Dandona, P.; Nix, D.; Wilson, M F.; Aljada, A.; Love, J.; Assicot, M.; Bohuon, C. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 1994, 79, 1605–1608. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Owen, W F.; Lowrie, E G. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998, 54, 627–636. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bologa, R M.; Levine, D M.; Parker, T S.; Cheigh, J S.; Serur, D.; Stenzel, K H.; Rubin, A L. IL-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am. J. Kidney Dis. 1998, 32, 107–114. [PUBMED], [INFOTRIEVE]
- Herbelin, A.; Urena, P.; Nquyen, A T.; Zingraff, J.; Descamps-Latscha, B. Elevated circulating levels of IL-6 in patients with chronic renal failure. Kidney Int. 1991, 39, 954–960. [PUBMED], [INFOTRIEVE]
- Aparicio, M.; Cano, N.; Chauveau, P.; Azar, R.; Canaud, B.; Flory, A.; Laville, M.; Leverse, X. Nutritional status of hemodialysis patients: a French national cooperative study. Nephrol. Dial. Transplant. 1999, 14, 1679–1686. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ulrich, C.; Kein, K.; Herman, W.; Kuhlmann, M.; , et al. Procalcitonin: a further acute phase parameter in patients undergoing hemodialysis. J. Am. Soc. Nephrol. 2000, 11, 501A.
- Nishikura, T. The clearance of procalcitonin during continuous venovenous hemodiafiltration. Intensive Care Med. 1999, 25, 1198–1201. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]